Sökning: WFRF:(Herlitz J) >
Efficacy, safety an...
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF
-
Deedwania, P. C. (författare)
-
Giles, T. D. (författare)
-
Klibaner, M. (författare)
-
visa fler...
-
Ghali, J. K. (författare)
-
- Herlitz, Johan, 1949 (författare)
- Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute,[external]
-
Hildebrandt, P. (författare)
-
Kjekshus, J. (författare)
-
Spinar, J. (författare)
-
Vitovec, J. (författare)
-
Stanbrook, H. (författare)
-
- Wikstrand, John, 1938 (författare)
- Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Wallenberglaboratoriet,Cardiovascular Institute,Wallenberg Laboratory
-
visa färre...
-
(creator_code:org_t)
- Mosby, Inc. 2005
- 2005
- Engelska.
-
Ingår i: Am Heart J. - : Mosby, Inc.. - 1097-6744 .- 0002-8703. ; 149:1, s. 159-67
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: The objective of the current study was to examine the efficacy and tolerability of the beta-blocker metoprolol succinate controlled release/extended release (CR/XL) in patients with diabetes in the Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). METHODS: The Cox proportional hazards model was used to calculate hazard ratios (HR) for convenience expressed as relative risks (risk reduction = 1-HR), and 95% confidence intervals (CI). RESULTS: The risk of hospitalization for heart failure was 76% higher in diabetics compared to non-diabetics (95% CI 38% to 123%). Metoprolol CR/XL was well tolerated and reduced the risk of hospitalization for heart failure by 37% in the diabetic group (95% CI 53% to 15%), and by 35% in the non-diabetic group (95% CI 48% to 19%). Pooling of mortality data from the Cardiac Insufficiency Bisoprolol Study II (CIBIS II), MERIT-HF, and the Carvedilol Prospective Randomized Cumulative Survival Study (COPERNICUS) showed similar survival benefits in patients with diabetes (25%; 95% CI 40% to 4%) and without diabetes (36%; 95% CI 44% to 27%); test of diabetes by treatment interaction was non-significant. Adverse events were reported more often on placebo than on metoprolol CR/XL. CONCLUSIONS: Patients with heart failure and diabetes have a much higher risk of hospitalization than patients without diabetes. Regardless of diabetic status, a highly significant reduction in hospitalizations for heart failure was observed with metoprolol CR/XL therapy, which was very well tolerated also by patients with diabetes. Furthermore, the pooled data showed a statistically significant survival benefit in patients with diabetes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Adrenergic beta-Antagonists/adverse effects/*therapeutic use
- Adult
- Aged
- Delayed-Action Preparations
- Diabetes Complications/*drug therapy/mortality
- Diabetes Mellitus/mortality
- Double-Blind Method
- Female
- Heart Failure
- Congestive/complications/*drug therapy
- Hospitalization
- Humans
- Male
- Metoprolol/adverse effects/*analogs & derivatives/*therapeutic use
- Middle Aged
- Proportional Hazards Models
- Risk
- Survival Analysis
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Deedwania, P. C.
-
Giles, T. D.
-
Klibaner, M.
-
Ghali, J. K.
-
Herlitz, Johan, ...
-
Hildebrandt, P.
-
visa fler...
-
Kjekshus, J.
-
Spinar, J.
-
Vitovec, J.
-
Stanbrook, H.
-
Wikstrand, John, ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
Am Heart J
- Av lärosätet
-
Göteborgs universitet
-
Högskolan i Borås